Acetaminophen; Benzhydrocodone Hydrochloride Patent Expiration

Acetaminophen; Benzhydrocodone Hydrochloride is Used for managing acute severe pain requiring an opioid analgesic when other treatments are insufficient. It was first introduced by Zevra Therapeutics in its drug Apadaz on Feb 23, 2018.


Acetaminophen; Benzhydrocodone Hydrochloride Patents

Given below is the list of patents protecting Acetaminophen; Benzhydrocodone Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Apadaz US8461137 Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof Feb 22, 2031 Zevra Therap
Apadaz US8748413 Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof Jul 01, 2030 Zevra Therap
Apadaz US8748413 Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof Jul 10, 2030 Zevra Therap
Apadaz US8828978 Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof Jul 01, 2030 Zevra Therap
Apadaz US9132125 Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof Jul 01, 2030 Zevra Therap
Apadaz US9549923 Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and uses thereof Jul 01, 2030 Zevra Therap


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳